New Tool for assessing the Prognosis of Chronic Heart Failure Patients ... Labmate Online Abbott has announced CE marking for the ARCHITECT® Galectin-3 assay, a test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure (HF). The test was developed in partnership with BG Medicine, Inc to run on Abbott's ... |
